FDA Warns of Elevidys Risks, Narrows Approval

The FDA issues a boxed warning for gene therapy Elevidys, linked to two patient deaths, narrowing its approved use to four-year-olds and older who can still walk. Sarepta Therapeutics, the drugs maker, faces challenges due to these developments. The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.